FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143559017> ?p ?o ?g. }

• W2143559017 endingPage "1343" @default.
• W2143559017 startingPage "1338" @default.
• W2143559017 abstract "We sought to assess the effects of cardiopulmonary bypass and profound hypothermic circulatory arrest on plasma cefazolin levels administered for antimicrobial prophylaxis in cardiovascular surgery.Four groups (10 patients per group) were prospectively studied: vascular surgery without cardiopulmonary bypass (group A), cardiac surgery with a cardiopulmonary bypass time of less than 120 minutes (group B), cardiac surgery with a cardiopulmonary bypass time of greater than 120 minutes (group C), and cardiac surgery with cardiopulmonary bypass and profound hypothermic circulatory arrest (group D). Subjects received cefazolin at induction and a second dose before wound closure. Arterial blood samples were obtained preceding cefazolin administration, at skin incision, hourly during the operation, and before redosing. Cefazolin plasma concentrations were determined by using a radial diffusion assay, with Staphylococcus aureus as the indicator microorganism. Cefazolin plasma concentrations were considered noninhibitory at 8 microg/mL or less, intermediate at 16 mug/mL, and inhibitory at 32 microg/mL or greater.In group A cefazolin plasma concentrations remained greater than 16 microg/mL during the complete surgical procedure. In group B cefazolin plasma concentrations diminished to 16 microg/mL or less in 30% of the patients but remained greater than 8 microg/mL. In group C cefazolin plasma concentrations decreased to less than 16 microg/mL in 60% of patients and were less than 8 microg/mL in 50% of patients. In group D cefazolin plasma concentrations reached 16 microg/mL in 66% of the patients but decreased to 8 microg/mL in only 1 patient.For patients undergoing cardiac surgery with a cardiopulmonary bypass time of greater than 120 minutes, a single dose of cefazolin before skin incision with redosing at wound closure does not provide targeted antimicrobial cefazolin plasma levels during the entire surgical procedure. Patients undergoing profound hypothermic circulatory arrest are better protected, but the described protocol of prophylaxis is not optimal." @default.
• W2143559017 created "2016-06-24" @default.
• W2143559017 creator A5004063560 @default.
• W2143559017 creator A5012009901 @default.
• W2143559017 creator A5018573013 @default.
• W2143559017 creator A5019886301 @default.
• W2143559017 creator A5024571142 @default.
• W2143559017 creator A5028109655 @default.
• W2143559017 creator A5048463274 @default.
• W2143559017 creator A5055607550 @default.
• W2143559017 creator A5060123512 @default.
• W2143559017 creator A5069228068 @default.
• W2143559017 date "2006-06-01" @default.
• W2143559017 modified "2023-10-01" @default.
• W2143559017 title "Plasma cefazolin levels during cardiovascular surgery: Effects of cardiopulmonary bypass and profound hypothermic circulatory arrest" @default.
• W2143559017 cites W2008787621 @default.
• W2143559017 cites W2021072458 @default.
• W2143559017 cites W2040041702 @default.
• W2143559017 cites W2061892908 @default.
• W2143559017 cites W2069094622 @default.
• W2143559017 cites W2086851819 @default.
• W2143559017 cites W2090118026 @default.
• W2143559017 cites W2113579227 @default.
• W2143559017 cites W2123305613 @default.
• W2143559017 cites W2134601423 @default.
• W2143559017 cites W2144626375 @default.
• W2143559017 cites W2326845225 @default.
• W2143559017 cites W2418354874 @default.
• W2143559017 cites W3140618944 @default.
• W2143559017 cites W4323238361 @default.
• W2143559017 cites W56502437 @default.
• W2143559017 doi "https://doi.org/10.1016/j.jtcvs.2005.11.047" @default.
• W2143559017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16733167" @default.
• W2143559017 hasPublicationYear "2006" @default.
• W2143559017 type Work @default.
• W2143559017 sameAs 2143559017 @default.
• W2143559017 citedByCount "37" @default.
• W2143559017 countsByYear W21435590172012 @default.
• W2143559017 countsByYear W21435590172013 @default.
• W2143559017 countsByYear W21435590172014 @default.
• W2143559017 countsByYear W21435590172015 @default.
• W2143559017 countsByYear W21435590172016 @default.
• W2143559017 countsByYear W21435590172017 @default.
• W2143559017 countsByYear W21435590172018 @default.
• W2143559017 countsByYear W21435590172020 @default.
• W2143559017 countsByYear W21435590172021 @default.
• W2143559017 countsByYear W21435590172022 @default.
• W2143559017 countsByYear W21435590172023 @default.
• W2143559017 crossrefType "journal-article" @default.
• W2143559017 hasAuthorship W2143559017A5004063560 @default.
• W2143559017 hasAuthorship W2143559017A5012009901 @default.
• W2143559017 hasAuthorship W2143559017A5018573013 @default.
• W2143559017 hasAuthorship W2143559017A5019886301 @default.
• W2143559017 hasAuthorship W2143559017A5024571142 @default.
• W2143559017 hasAuthorship W2143559017A5028109655 @default.
• W2143559017 hasAuthorship W2143559017A5048463274 @default.
• W2143559017 hasAuthorship W2143559017A5055607550 @default.
• W2143559017 hasAuthorship W2143559017A5060123512 @default.
• W2143559017 hasAuthorship W2143559017A5069228068 @default.
• W2143559017 hasBestOaLocation W21435590171 @default.
• W2143559017 hasConcept C126322002 @default.
• W2143559017 hasConcept C141071460 @default.
• W2143559017 hasConcept C2778353156 @default.
• W2143559017 hasConcept C2778789114 @default.
• W2143559017 hasConcept C2778881276 @default.
• W2143559017 hasConcept C42219234 @default.
• W2143559017 hasConcept C501593827 @default.
• W2143559017 hasConcept C71924100 @default.
• W2143559017 hasConcept C72859922 @default.
• W2143559017 hasConcept C86803240 @default.
• W2143559017 hasConcept C89423630 @default.
• W2143559017 hasConceptScore W2143559017C126322002 @default.
• W2143559017 hasConceptScore W2143559017C141071460 @default.
• W2143559017 hasConceptScore W2143559017C2778353156 @default.
• W2143559017 hasConceptScore W2143559017C2778789114 @default.
• W2143559017 hasConceptScore W2143559017C2778881276 @default.
• W2143559017 hasConceptScore W2143559017C42219234 @default.
• W2143559017 hasConceptScore W2143559017C501593827 @default.
• W2143559017 hasConceptScore W2143559017C71924100 @default.
• W2143559017 hasConceptScore W2143559017C72859922 @default.
• W2143559017 hasConceptScore W2143559017C86803240 @default.
• W2143559017 hasConceptScore W2143559017C89423630 @default.
• W2143559017 hasIssue "6" @default.
• W2143559017 hasLocation W21435590171 @default.
• W2143559017 hasLocation W21435590172 @default.
• W2143559017 hasOpenAccess W2143559017 @default.
• W2143559017 hasPrimaryLocation W21435590171 @default.
• W2143559017 hasRelatedWork W1977157226 @default.
• W2143559017 hasRelatedWork W2049733093 @default.
• W2143559017 hasRelatedWork W2143559017 @default.
• W2143559017 hasRelatedWork W2419542726 @default.
• W2143559017 hasRelatedWork W2809981769 @default.
• W2143559017 hasRelatedWork W2811121752 @default.
• W2143559017 hasRelatedWork W3103510489 @default.
• W2143559017 hasRelatedWork W3129089517 @default.
• W2143559017 hasRelatedWork W3197651521 @default.
• W2143559017 hasRelatedWork W4206637151 @default.
• W2143559017 hasVolume "131" @default.

• next